Drawing for ELYPTA

USPTO serial 79299955

ELYPTA

Reviewed by CopyMark Law Group

Reg. 6604442Status 700Registered
Filing date
Status date
Registration date
Jan 4, 2022
Examiner
MEYERS, MORGAN LAURA
Law office
TMO LAW OFFICE 117

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELYPTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use * within the therapeutic area of oncology * [ in oncology ] ; diagnostic preparations for medical and veterinary use in oncology; diagnostic agents for medical use in the field of oncologyACTIVE
009Recorded programs for computer, namely software to record, analyze and monitor data from biological samples in the field of oncology; downloadable computer software to record, analyze and monitor data from biological samples in the field of oncology; scientific research and laboratory apparatus to test, analyze and measure biological samples for cancer indications, for research use; colorimeters, other than for medical diagnostic use; downloadable computer software for diagnosing and monitoring cancer for use in medical decision support systemsACTIVE
010Medical and veterinary apparatus and instruments for diagnosing and monitoring cancer; membrane test plates for use in medical diagnostics in the therapeutic area of oncologyACTIVE
044Human healthcare services; medical services; technical consultancy services in the field of oncology; performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical testing for diagnostic or treatment purposes; medical services for the diagnosis of conditions of the human body; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pathology services; providing cancer screening services; bowel cancer screening services; prostate cancer screening services; testicular cancer screening services; breast cancer screening services; cervical cancer screening services; screening for hepatitis; services for the testing of sera; services for the testing of blood; services for the testing of urine; nursing care; medical care; outpatient and inpatient care servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 9, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 9, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 17, 2023INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 22, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 11, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 12, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 22, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 22, 2022FIMPFINAL DISPOSITION PROCESSED
Jun 22, 2022LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Jun 22, 2022COC.CORRECTION UNDER SECTION 7 - PROCESSED
Jun 22, 2022PLGLASSIGNED TO PARALEGAL
May 14, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB
Apr 4, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 4, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2021ALIEASSIGNED TO LIE
Sep 2, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2021RFNTREFUSAL PROCESSED BY IB
Mar 4, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 2, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021DOCKASSIGNED TO EXAMINER
Dec 22, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Dec 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance